Biology subjects

Janahi, M.

Publications and source records attributed to Janahi, M..

3 recordsLinked to original sources

bioRxiv2025

Incorporating Multi-threshold Polygenic Risk in Hippocampal-based Normative Models Improves Cognitive Decline Prediction

Predicting cognitive decline using MRI measures of brain volume is challenging. Normative models capture the evolution of biomarkers over time in a healthy group, quantifying an individuals deviation from that norm. Here, we improve the precision of normative models for hippocampal volume, a key cognitive biomarker, by integrating multi-threshold polygenic scores (PGS) that capture genetic predisposition to its variability. We built Gaussian Process Regression (GPR) models on genetic, imaging, and demographic data from 23,997 UK Biobank (UKBB) participants, validating on 3,000 out-of-sample participants from the Alzheimers Disease Neuroimaging Initiative (ADNI) and the European Prevention of Alzheimers Disease (EPAD) cohorts. The genetically-informed models improved associations significantly across five experimental designs and 13 key neurocognitive measures, including Mini-Mental State Examination (MMSE), Clinical Dementia Rating (CDR), Alzheimers Disease Assessment Scale (ADAS), and importantly, improving prediction of future cognitive decline. These findings underscore the value of integrating multi-threshold PGS with neuroimaging-based predictive models for improving prognostication in neurodegenerative diseases.

bioinformatics↗

bioRxiv2022

Nomograms of Human Hippocampal Volume Shifted by Polygenic Scores

Nomograms are important clinical tools applied widely in both developing and aging populations. They are generally constructed as normative models identifying cases as outliers to a distribution of healthy controls. Currently used normative models do not account for genetic heterogeneity. Hippocampal Volume (HV) is a key endophenotype for many brain disorders. Here, we examine the impact of genetic adjustment on HV nomograms and the translational ability to detect dementia patients. Using imaging data from 35,686 healthy subjects aged 44 to 82 from the UK BioBank (UKBB), we built HV nomograms using gaussian process regression (GPR), extending the application age by 20 years, including dementia critical age ranges. Using HV Polygenic Scores (HV-PGS), we built genetically adjusted nomograms from participants stratified into the top and bottom 30% of HV-PGS. This shifted the nomograms in the expected directions by [~]100 mm3 (2.3% of the average HV), which equates to 3 years of normal aging. Clinical impact of genetically adjusted nomograms was investigated by comparing 818 subjects from the AD neuroimaging (ADNI) database diagnosed as either cognitively normal (CN), having mild cognitive impairment (MCI) or Alzheimers disease patients (AD). While no significant change in the survival analysis was found for MCI-to-AD conversion, an average of 4% decrease was found in intra-diagnostic-group variance, highlighting the importance of genetic adjustment in untangling phenotypic heterogeneity.

bioinformatics↗

bioRxiv2019

A Metagenomics - Based Diagnostic Approach for Central Nervous System Infections in Hospital Acute Care Setting

The etiology of central nervous system (CNS) infections such as meningitis and encephalitis remains unknown in a large proportion of cases partly because the diversity of pathogens that may cause CNS infections greatly outnumber available test methods. Here we present a metagenomic next generation sequencing (mNGS) based approach for broad-range detection of pathogens associated with CNS infections, which is suitable for application in the acute care hospital setting. Using an Illumina MiSeq benchtop sequencer and the IDseq pipeline for identifying pathogens in metagenomic sequence data, we show that the analytical sensitivity of mNGS to detect pathogens is comparable to that of PCR in simulated cerebrospinal fluid (CSF) specimens. We then applied this method for pathogen detection in 74 CSF specimens from patients with suspected CNS infections that were previously tested by culture and/or PCR. Diagnostic accuracy, sensitivity and specificity of mNGS approach with reference to conventional methods were all 95%. Furthermore, confirmatory testing on specimens that gave discrepant results were mostly in favor of the mNGS assay. The clinical application of mNGS holds promise to benefit patients with CNS infections of unknown etiology.

pathology↗